Searched for
DRUG QUALITY OVERSIGHT
Death rate in ICE immigrant detention centers more than doubles under Trump, Reuters analysis findsFifty individuals have died in U.S. immigration detention since January 2025, a rate that has more than doubled since 2009. Concerns are ri...- Drug regulator oversight sought for nutraceuticals; NGO flags quality, pricing concernsA Gujarat NGO is pushing the government to regulate nutraceuticals like medicines. They cite concerns about product quality and unregulated...
- Drugmaker Granules to tighten oversight after US FDA warning, executive saysThe company, which is globally one of the largest paracetamol makers and a major player in the active pharmaceutical ingredients market, de...
- Indian drugmaker Granules to tighten oversight after US FDA warning, exec saysAmid growing scrutiny from the U.S. FDA over documentation practices and contamination issues, Granules India is reinforcing its manufactur...
- Govt orders safety review of popular weight-loss drugs amid rising demandIndian authorities are increasing vigilance on popular weight loss drugs. Indian Pharmacopoeia Commission will now compile reports on adver...
- Regulating pharma, beyond manufacturing qualityIn a significant leap forward, India's drug authority, CDSCO, is poised for a transformative upgrade. The government is embarking on an ini...
- Drug regulator steps up oversight on product changes after approvalDrug makers now need government approval for any quality changes to medicines. This applies to alterations affecting a drug's identity, str...
- Quality issues: Regulator looks to tighten marketing & sale of drugsIndia's drug regulator plans new rules for medicine marketers. Companies will need a license to sell and distribute drugs. This aims to imp...
- Check health vitals: The complexities of medical regulationsThe recent string of unfortunate events brings to light severe shortcomings within India's health sector regulations. The deaths linked to ...
- China to 'refine' centralized medicine procurement policiesChina will refine its centralized drug procurement policy following a probe into off-patent medicine quality, aiming to enhance evaluations...
- One nation, one check: India needs centralised drug regulation to ensure public healthCentralisation of drug regulation in India is critical to ensure consistent drug quality and safety standards nationwide. The current fragm...
- USFDA pulls up Intas Pharma for manufacturing lapses at Ahmedabad plantIn a warning letter to the company's CEO and MD Nimish Chudgar, the US Food and Drug Administration (USFDA) has pointed out various manufac...
- Rx quality control for reputation and livesReplace the existing regulatory system with a modern legal structure that provides oversight to an increasingly complex pharma industry, wh...
- Quality of pharma must not be strainedNews that 48 common drugs manufactured in India failed to meet quality standards comes as little surprise. The absence of a robust drug reg...
- Five ways pharmaceutical and healthcare sectors can be ‘Modified’The government has targeted to increase GDP expenditure on healthcare to 2.5 per cent by 2025.
- Ex-FDA chief Scott Gottlieb endorses use of generic drugsGottlieb, 46, who resigned in the middle of his tenure in March this year, has been tweeting to convince patients that generic drugs are sa...
- USFDA issues warning letter to USV Pvt over Daman plantThe warning letter to Managing Director Prashant K Tewari raised similar current good manufacturing practice (CGMP) violations at its other...
- Whistleblower raises questions on DCGI, drug regulatory systemIn a writ petition filed at the Supreme Court of India, Thakur has sued the health ministry , Central Drugs Standard Control Organisation .
- Apollo Pharmacy reviewing quality of Ranbaxy drugs"We haven't suspended the drugs per se, but our medical oversight committee has asked for FDA and GMP certificate for medicines that we dis...
- US Congress member Steve Israel seeks review of FDA's Ranbaxy probeSteve Israel, a member of the US Congress, has sought a complete review of the US FDA's probe into Ranbaxy Labs, which dragged on for eight...
Load More
